MarketPulse
T

$TNDM

4 articles found
2 positive
2 negative
0 neutral
BenzingaBenzinga··Vandana Singh

FDA Issues Class I Recall for Tandem Diabetes Mobi Pumps Over Insulin Delivery Risk

FDA classifies Class I recall for Tandem Diabetes' Mobi insulin pumps due to false motor failure detection risking insulin delivery interruption.
TNDMFDA recallmedical device
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Tandem Diabetes Care Faces Securities Fraud Investigation After Pump Malfunction Disclosure

The Portnoy Law Firm investigates $TNDM after a 19.9% stock plunge triggered by insulin pump malfunction disclosures that could halt insulin delivery.
TNDMsecurities fraudinvestor losses
GlobeNewswire Inc.GlobeNewswire Inc.··Custom Market Insights

IV Infusion Pump Market to Double to $14B by 2035 on Aging, Tech Gains

Global IV infusion pump market projected to grow from $6.72B in 2025 to $14.02B by 2035 at 7.6% CAGR, driven by aging populations and smart pump technology.
MDTTNDMBAXBDXICUImedical deviceshealthcare market
BenzingaBenzinga··Vandana Singh

Tandem Diabetes Surges on Profitability Inflection, Beats Earnings Expectations

Tandem Diabetes surged after beating earnings expectations with a profitability turnaround. The insulin pump maker posted better-than-expected revenue and swung to adjusted profitability.
TNDMprofitabilityguidance